Research suggests statins may reduce risk of prostate cancer
Prostate cancer affects an estimated 200,000 men in the U.S. each year, many of whom buy Flomax in order to reduce symptoms such as pain and difficulty urinating.
Prostate cancer affects an estimated 200,000 men in the U.S. each year, many of whom buy Flomax in order to reduce symptoms such as pain and difficulty urinating. Smart shoppers who are looking to save money on such medications may look into a Canadian online pharmacy, which offers drugs at a reasonable price.
This may be good news for men who have the disease, as treatments are often pricey. Scientists are continuing to explore new, cost-effective avenues of alleviating prostate cancer symptoms or reducing the risk of the ailment entirely.
In fact, a recent study that was presented at the Prostate Cancer Research Program conference suggests that the use of statins may be a viable method of reducing the risk of the ailment. This type of medication, which is commonly used to lower cholesterol, has been shown to reduce men's likelihood of developing prostate cancer by 60 percent.
"Few risk factors for high-grade prostate cancer are known and few prevention strategies exist," said physician Wildon Farwell of Brigham and Women's Hospital. "Learning more about the relationship between statins and prostate cancer may provide important clues into the basic biology of [the disease]."
In the meantime, patients may opt for established medications from a Canadian online pharmacy to relieve their symptoms.
|
